Dock Street Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Dock Street Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,715	Closed	-$3.97M	–	63
2022 Q2	$3.97M	Sell	6,715 -53	-0.8%	-$34.5K	0.87%	25
2022 Q1	$4.73M	Sell	6,768 -76	-1%	-$48.1K	0.85%	26
2021 Q4	$4.32M	Buy	6,844 +119	+2%	+$73.2K	0.71%	29
2021 Q3	$4.07M	Buy	6,725 +41	+0.6%	+$25.5K	0.76%	31
2021 Q2	$3.73M	Sell	6,684 -1,055	-14%	-$534K	0.7%	30
2021 Q1	$3.66M	Buy	7,739 +154	+2%	+$75K	0.76%	29
2020 Q4	$3.66M	Buy	+7,585	New	+$4.09M	0.76%	29

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dock Street Asset Management's REGN Position: Q3 2022 in Review

Dock Street Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2022, closing a stake of 6,715 shares — an estimated $3.97M sold.

Dock Street Asset Management first reported a position in REGN in Q4 2020 and held it in 7 quarters. The position peaked at $4.73M in Q1 2022. 1,080 funds tracked by Wall St. Rank hold REGN as of Q3 2022.

Dock Street Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Dock Street Asset Management sold 6,715 Regeneron Pharmaceuticals shares in Q3 2022, an estimated $3.97M.
Dock Street Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2020 and held it in 7 quarters.
Dock Street Asset Management's Regeneron Pharmaceuticals position peaked at $4.73M in Q1 2022.
1,080 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2022.

Based on Dock Street Asset Management's 13F filing for Q3 2022, filed 25 Oct 2022.